Joseph L. Waner

1.4k total citations
48 papers, 1.1k citations indexed

About

Joseph L. Waner is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Joseph L. Waner has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 13 papers in Immunology and 10 papers in Infectious Diseases. Recurrent topics in Joseph L. Waner's work include Cytomegalovirus and herpesvirus research (19 papers), Respiratory viral infections research (16 papers) and Herpesvirus Infections and Treatments (8 papers). Joseph L. Waner is often cited by papers focused on Cytomegalovirus and herpesvirus research (19 papers), Respiratory viral infections research (16 papers) and Herpesvirus Infections and Treatments (8 papers). Joseph L. Waner collaborates with scholars based in United States, Japan and Canada. Joseph L. Waner's co-authors include G. Plummer, Thomas H. Weller, Clyde R. Goodheart, Sherwin V. Kevy, Paula C. Murphy, Dan Engelhard, Robert A. Good, Neena Kapoor, Anan Phuangsab and William C. Feng and has published in prestigious journals such as The Journal of Immunology, Clinical Microbiology Reviews and Journal of Virology.

In The Last Decade

Joseph L. Waner

45 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph L. Waner United States 20 886 304 174 130 116 48 1.1k
M. Colin Jordan United States 19 1.2k 1.3× 383 1.3× 175 1.0× 76 0.6× 124 1.1× 27 1.5k
R. B. Heath United Kingdom 22 1.0k 1.2× 421 1.4× 290 1.7× 184 1.4× 101 0.9× 70 1.5k
M Just Switzerland 24 1.0k 1.2× 356 1.2× 349 2.0× 89 0.7× 142 1.2× 86 1.7k
Robert L. Magoffin United States 16 1.0k 1.1× 492 1.6× 183 1.1× 85 0.7× 51 0.4× 37 1.3k
J. Nagington United Kingdom 21 521 0.6× 267 0.9× 128 0.7× 187 1.4× 60 0.5× 52 1.5k
Therese Popow‐Kraupp Austria 22 1.3k 1.5× 524 1.7× 142 0.8× 68 0.5× 71 0.6× 47 1.6k
Ronald D. Tyler United States 18 380 0.4× 226 0.7× 67 0.4× 67 0.5× 113 1.0× 49 1.0k
Robert M. Coleman United States 15 407 0.5× 180 0.6× 84 0.5× 70 0.5× 71 0.6× 45 798
Allan M. Arbeter United States 21 736 0.8× 150 0.5× 139 0.8× 54 0.4× 115 1.0× 39 936
Arne Svedmyr Sweden 21 552 0.6× 537 1.8× 90 0.5× 153 1.2× 134 1.2× 65 1.2k

Countries citing papers authored by Joseph L. Waner

Since Specialization
Citations

This map shows the geographic impact of Joseph L. Waner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph L. Waner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph L. Waner more than expected).

Fields of papers citing papers by Joseph L. Waner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph L. Waner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph L. Waner. The network helps show where Joseph L. Waner may publish in the future.

Co-authorship network of co-authors of Joseph L. Waner

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph L. Waner. A scholar is included among the top collaborators of Joseph L. Waner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph L. Waner. Joseph L. Waner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gulati, Upma, Wenxin Wu, Shelly Gulati, et al.. (2005). Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. Virology. 339(1). 12–20. 41 indexed citations
2.
Waner, Joseph L., et al.. (2003). Laboratory-acquired vaccinia infection. Journal of Clinical Virology. 29(3). 167–170. 23 indexed citations
3.
Waner, Joseph L.. (1999). Detection of Respiratory Viruses: Is There a Need for Molecular Methods?. Clinical Microbiology Newsletter. 21(10). 80–82.
4.
Subbarao, Kanta, Judy A. Beeler, & Joseph L. Waner. (1994). A conformational epitope on the dimer of the fusion protein of respiratory syncytial virus detected in natural infections. Clinical and Diagnostic Virology. 1(5-6). 313–323. 2 indexed citations
5.
Ogle, John W., et al.. (1991). Absence of interferon in sera of patients with Kawasaki syndrome. The Pediatric Infectious Disease Journal. 10(1). 25–29. 5 indexed citations
6.
Waner, Joseph L., et al.. (1991). Comparison of Directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus. Journal of Clinical Microbiology. 29(3). 479–482. 97 indexed citations
7.
Waner, Joseph L., et al.. (1990). Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus. Journal of Clinical Microbiology. 28(3). 480–483. 49 indexed citations
8.
Subbarao, Kanta, et al.. (1989). Detection of multiple viral agents in nasopharyngeal specimens yielding Respiratory Syncytial Virus (RSV). Diagnostic Microbiology and Infectious Disease. 12(4). 327–332. 25 indexed citations
9.
Subbarao, Kanta, et al.. (1987). Comparison of two enzyme-linked immunosorbent assay (EIA) kits with immunofluorescence and isolation in cell culture for detection of respiratory syncytial virus (RSV). Diagnostic Microbiology and Infectious Disease. 8(4). 229–234. 7 indexed citations
10.
Waner, Joseph L., et al.. (1983). Blastogenic response of human lymphocytes to early antigen(s) of human cytomegalovirus. Infection and Immunity. 41(3). 1084–1088. 3 indexed citations
11.
Rose, Richard M., Clyde S. Crumpacker, Joseph L. Waner, & Joseph D. Brain. (1983). Treatment of murine cytomegalovirus pneumonia with acyclovir and interferon.. PubMed. 127(2). 198–203. 8 indexed citations
12.
Rose, Richard M., Clyde S. Crumpacker, Joseph L. Waner, & Joseph D. Brain. (1982). Murine Cytomegalovirus Pneumonia. American Review of Respiratory Disease. 125(5). 568–573. 9 indexed citations
13.
Cruz, José Ramiro, Gustave J. Dammin, & Joseph L. Waner. (1981). Protective effect of low-dose interferon against neonatal murine cytomegalovirus infection. Infection and Immunity. 32(1). 332–342. 6 indexed citations
14.
Feng, William C., et al.. (1979). Natural infection of dogs on Cape Cod with Rickettsia rickettsii. Journal of Clinical Microbiology. 10(3). 322–325. 11 indexed citations
15.
Waner, Joseph L. & Thomas H. Weller. (1978). Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera. Infection and Immunity. 21(1). 151–157. 46 indexed citations
16.
Waner, Joseph L., et al.. (1978). Effect of rhesus or vervet cytomegalovirus infection of DNA synthesis in untreated and 5-iodo-2'-deoxyuridine-arrested cells. Journal of Virology. 25(2). 465–470. 1 indexed citations
17.
Feinsod, Fred M., Andrew Spielman, & Joseph L. Waner. (1975). Neutralization of Sindbis Virus by Antisera to Antigens of Vector Mosquitoes. American Journal of Tropical Medicine and Hygiene. 24(3). 533–536. 7 indexed citations
18.
Waner, Joseph L., et al.. (1973). Three-Day Assay for Human Cytomegalovirus Applicable to Serum Neutralization Tests. Applied Microbiology. 25(1). 37–39. 1 indexed citations
19.
Waner, Joseph L., et al.. (1973). Three-Day Assay for Human Cytomegalovirus Applicable to Serum Neutralization Tests. Applied Microbiology. 25(1). 37–39. 7 indexed citations
20.
Plummer, G., et al.. (1968). Comparative studies of type 1 and type 2 & 'herpes simplex' viruses.. PubMed. 49(2). 202–8. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Colin Jordan Breakdown of academic impact, for papers by R. B. Heath Breakdown of academic impact, for papers by M Just Breakdown of academic impact, for papers by Robert L. Magoffin Breakdown of academic impact, for papers by J. Nagington Breakdown of academic impact, for papers by Therese Popow‐Kraupp Breakdown of academic impact, for papers by Ronald D. Tyler Breakdown of academic impact, for papers by Robert M. Coleman Breakdown of academic impact, for papers by Allan M. Arbeter Breakdown of academic impact, for papers by Arne Svedmyr
Rankless by CCL
2026